Andrew H. Ko

MD

Gastrointestinal cancer specialist
East Coast transplant, lover of music and sports

Dr. Andrew H. Ko is a specialist in digestive system cancers. He provides compassionate and individualized care for patients with cancers of the pancreas, stomach and esophagus.

In research, Ko has long been active in developing and evaluating new treatments for gastrointestinal cancers, including molecularly targeted agents and immune-based therapies.

Ko earned an undergraduate degree in applied mathematics and biology at Brown University. He earned his medical degree at the Johns Hopkins University School of Medicine. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School, and completed a fellowship in medical oncology at Stanford University. He joined UCSF in 2001.

  • Education

    Johns Hopkins University, 1995

  • Residencies

    Beth Israel Hospital-Boston, MA, Internal Medicine, 1998

  • Fellowships

    Stanford University Medical Center, 2001

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Professor

I am honored to partner with patients as I provide compassionate, thoughtful and cutting-edge care during a challenging time in their lives.

Conditions I specialize in

Where I see patients (2)

    My reviews

    4.9

    Overall Experience
    208 Ratings
    About our process
    Dec 19, 2024
    Dr. Ko is excellent and very compassionate and explains things very well.
    Dec 19, 2024
    Dr. Ko has incredible depth, and vast knowledge and experience. He is caring, an excellent listener and a skilled communicator who has a unique ability to frame complex information in a clear, understandable way. I felt cared about and cared for. I have so much confidence in my treatment going forward because of Dr. Ko.
    Nov 23, 2024
    Dr. Ko is a really nice person and doctor. He listened and explained to me very patiently and carefully. He's awesome.
    Nov 21, 2024
    Very nice provider. Very caring.
    Nov 19, 2024
    Andrew Ko is the best in all ways an oncologist should be both by advanced knowledge and empathetic patient care
    Nov 03, 2024
    Dr. Ko is a superb oncologist.
    Oct 16, 2024
    Dr. Ko is amazing and gave me hope when I thought there was none. He also encouraged me to live my life to the fullest extent possible during treatment and to stay active and social as long as my friends are not sick with colds or viruses.
    Oct 08, 2024
    Dr Ko is exceptional and has always made me feel like a "special" patient
    Sep 24, 2024
    Dr. Ko is a fabulous provider!
    Sep 17, 2024
    Outstanding communication by all.
    Jun 29, 2024
    Dr. Ko is the best!
    Jun 21, 2024
    For the type of cancer I experienced you cant find better than Andrew Ko
    May 28, 2024
    Dr. Ko is great!!! He listens intently, and is a very kind Dr.
    May 02, 2024
    Dr. KO has been an exceptional care provider towards me
    Apr 28, 2024
    It was a very good experience
    Apr 18, 2024
    Both Dr. Feng and Dr. Ko are very easy to understand and take time to listen and answer all my questions.
    Mar 19, 2024
    Wonderful experience (as always!)!
    Nov 30, 2023
    I have the up most respect for Dr. Ko.
    Nov 09, 2023
    Dr ok was amazing
    Oct 19, 2023
    Dr. Ko is prepared for our meetings. He's obviously reviewed my chart from our very first visit and speaks with knowledge about my treatment and response to treatment. I have never needed to remind Dr. Ko of something related to my cancer treatment.
    Oct 06, 2023
    I recommend UCSF and Dr. Ko regularly
    Sep 04, 2023
    I needed more specifics regarding the stage of my cancer, and the prognosis based on the recommended treatment.
    Aug 17, 2023
    Doctor KO is a very good, caring provider, I would recommend him to others i!
    Aug 06, 2023
    Dr. Ko is very kind, listens well, and is an expert in his field.
    Aug 03, 2023
    Can't receive any better responses to my treatment.
    Jul 27, 2023
    I saw Dr. Andrew Ko for a second opinion about my terminal cancer. He had reviewed my history, answered all of my questions and gave me really good advice.
    Jul 13, 2023
    Very pleasant, knowledgeable, and caring gentleman!
    Jun 15, 2023
    Dr. Ko listened to my concerns, answered all questions. His knowledge about my condition was Impressive and he gave me important information that I really needed to know.
    Jun 04, 2023
    Doctor Ko is the best doctor I've ever had
    May 18, 2023
    My care provider is so easy to talk to!Even tho I was scared to talk to him at the beginning, I feel very comfortable to talk to him now!
    Mar 28, 2023
    The visit was very helpful and I very much appreciated the opportunity to have the visit. I was able to gain some important understandings about my illness and its treatment.
    Mar 17, 2023
    Dr. Ko was very pleasant. I would have loved to have had an opportunity to sit and discuss options for dealing with my pancreatic cancer. He was very nice but I'm not sure how to implement some of the suggestions he gave me, though some were great!
    Mar 07, 2023
    Would happily recommend Dr. Ko to others!

    Selected research

    See all research
    Decorative Caduceus

    Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Can...

    Overall survival is defined as the time from randomization to death due to any cause. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator. The treatment arms will be compared using a stratified C...

    Recruiting

    Decorative Caduceus

    A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIR...

    Recruiting

    Decorative Caduceus

    The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2...

    Will be assessed by the proportion of patients who achieve complete response (CR) or partial response (PR) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) during the protocol treatment. Fisher's exact te...

    Recruiting

    Decorative Caduceus

    Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients Wit...

    Assessment of Dose-limiting toxicities (DLTs)

    Recruiting

    Contact me

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF are covered by every insurance plan.
    This provider is employed by a medical group affiliated with UCSF.

    Share